Bank of Nova Scotia’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.91M | Buy |
+228,731
| New | +$3.91M | 0.01% | 549 |
|
|
2025
Q1 | – | Sell |
-67,666
| Closed | -$8.23M | – | 1000 |
|
|
2024
Q4 | $8.23M | Sell |
67,666
-185,102
| -73% | -$22.5M | 0.01% | 447 |
|
|
2024
Q3 | $31.6M | Sell |
252,768
-57
| -0% | -$7.12K | 0.06% | 184 |
|
|
2024
Q2 | $39.9M | Sell |
252,825
-168,711
| -40% | -$26.7M | 0.08% | 175 |
|
|
2024
Q1 | $54.6M | Sell |
421,536
-107,257
| -20% | -$13.9M | 0.11% | 148 |
|
|
2023
Q4 | $51M | Buy |
+528,793
| New | +$51M | 0.1% | 162 |
|
|
2022
Q4 | – | Sell |
-14,000
| Closed | -$1.55M | – | 1207 |
|
|
2022
Q3 | $1.55M | Sell |
14,000
-124,000
| -90% | -$13.7M | ﹤0.01% | 703 |
|
|
2022
Q2 | $10.3M | Buy |
138,000
+10,000
| +8% | +$750K | 0.02% | 364 |
|
|
2022
Q1 | $10M | Buy |
128,000
+115,777
| +947% | +$9.04M | 0.02% | 451 |
|
|
2021
Q4 | $1.1M | Sell |
12,223
-196,895
| -94% | -$17.7M | ﹤0.01% | 928 |
|
|
2021
Q3 | $19.3M | Buy |
209,118
+202,759
| +3,189% | +$18.8M | 0.03% | 338 |
|
|
2021
Q2 | $494K | Buy |
+6,359
| New | +$494K | ﹤0.01% | 949 |
|
|
2020
Q4 | – | Sell |
-65,098
| Closed | -$9.14M | – | 1019 |
|
|
2020
Q3 | $9.14M | Buy |
65,098
+35,922
| +123% | +$5.04M | 0.02% | 353 |
|
|
2020
Q2 | $4.68M | Buy |
+29,176
| New | +$4.68M | 0.02% | 429 |
|
|
2019
Q4 | – | Sell |
-64,392
| Closed | -$4.85M | – | 970 |
|
|
2019
Q3 | $4.85M | Buy |
64,392
+58,117
| +926% | +$4.38M | 0.01% | 500 |
|
|
2019
Q2 | $954K | Sell |
6,275
-1,725
| -22% | -$262K | ﹤0.01% | 711 |
|
|
2019
Q1 | $954K | Sell |
8,000
-18,000
| -69% | -$2.15M | ﹤0.01% | 707 |
|
|
2018
Q4 | $2.84M | Buy |
+26,000
| New | +$2.84M | 0.01% | 502 |
|
|
2018
Q2 | – | Sell |
-24,700
| Closed | -$1.83M | – | 915 |
|
|
2018
Q1 | $1.83M | Buy |
+24,700
| New | +$1.83M | 0.01% | 577 |
|
|
2017
Q4 | – | Sell |
-121,767
| Closed | -$5.52M | – | 945 |
|
|
2017
Q3 | $5.52M | Buy |
+121,767
| New | +$5.52M | 0.03% | 348 |
|